PT  - JOURNAL ARTICLE
AU  - Yu, Qingzhao
AU  - Cao, Wentao
AU  - Hamer, Diana
AU  - Urbanek, Norman
AU  - Straif-Bourgeois, Susanne
AU  - Cormier, Stephania
AU  - Ferguson, Tekeda
AU  - Richmond-Bryant, Jennifer
TI  - Risk factors among Black and White COVID-19 patients from a Louisiana Hospital System, March, 2020 – August, 2021
AID  - 10.1101/2022.07.27.22278118
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.27.22278118
4099  - http://medrxiv.org/content/early/2022/07/29/2022.07.27.22278118.short
4100  - http://medrxiv.org/content/early/2022/07/29/2022.07.27.22278118.full
AB  - Objectives To investigate relationships between race and COVID-19 hospitalizations, intensive care unit (ICU) admissions, and mortality over time and which characteristics, may mediate COVID-19 associations.Methods We analyzed hospital admissions, ICU admissions, and mortality among positive COVID-19 cases within the ten-hospital Franciscan Ministries of Our Lady Health System around the Mississippi River Industrial Corridor in Louisiana over four waves of the pandemic from March 1, 2020 – August 31, 2021. Associations between race and each outcome were tested, and multiple mediation analysis was performed to test if other demographic, socioeconomic, or air pollution variables mediate the race-outcome relationships.Results Race was associated with each outcome over the study duration and during most waves. Early in the pandemic, hospitalization, ICU admission, and mortality rates were greater among Black patients, but as the pandemic progressed these rates became greater in White patients. However, Black patients were still disproportionately represented in these measures. Age was a significant mediator for all outcomes across waves, while comorbidity and emissions of naphthalene and chloroprene acted as mediators for the full study period.Conclusions The role of race evolved throughout the pandemic in Louisiana, but Black patients bore a disproportionate impact. Naphthalene and chloroprene air pollution partially explained the long-term associations. Our findings imply that air pollution might contribute to the increased COVID-19 hospitalizations and mortality among Black residents in Louisiana but likely do not explain most of the effect of race.What is already known on this topic Early in the pandemic, there was evidence of disparities in COVID-19 cases, hospitalizations, intensive care unit (ICU) admissions, and mortality due to race. Studies were emerging to indicate that strength of these relationships was waning over time.What this study adds This study tests relationships between race and hospitalizations, ICU admissions, and mortality and finds that Black patients continue to be disproportionately represented, although that inequity diminished over time. This study, the first to use multiple mediation analysis to study COVID-19 associations, suggests that the relationship between race and health outcome can be explained by mediators including age and, to a lesser extent, comorbidity and air pollution.How this study might affect research, practice or policy This study supports the need for healthcare resources to be available to Louisiana’s communities of color, for policy to support increased access to health care in the Industrial Corridor region, and for policy to support the reduction of air pollution emissions to disproportionately impacting the health of the Industrial Corridor’s communities of color.Competing Interest StatementThe authors have declared no competing interest.Funding StatementQ. Yu, W. Cao, S. Cormier, and J. Richmond-Bryant were supported in part by the National Institute for Environmental Health Sciences Louisiana Superfund Research Program (5 P42 E13648-08A1). T. Ferguson was supported in part by the National Institute of Alcohol Abuse and Alcoholism (2 P60 AA09803-22). N. Urbanek was supported by the North Carolina State University College of Natural Resources Office of Diversity and Inclusion.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Louisiana State University Health Sciences Center IRB approved our protocol (#1986) for a data analysis involving de-identified patient data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not publicly available.